Loch Duart salmon farm has partnered with award winning environmental organisation Plan Bee Ltd. to protect Scotland’s unique pollinators, the honey and bumble bees.
Major appointment for the HALO
The HALO Urban Regeneration Company today announces a major appointment to its Board.
Appointment of new Entrepreneurial Scotland Chair
Colin Robertson, Chief Executive Officer of Alexander Dennis, will take over the role from departing Chair, Chris van der Kuyl of 4J Studios
Colin Robertson, Chief Executive Officer of one of the world’s leading bus and coach manufacturing companies Alexander Dennis Limited (ADL), has been appointed as the new Chair of Entrepreneurial Scotland (ES).
Kyowa Kirin Announces Mogamulizumab Received Positive CHMP Opinion for Treatment of Mycosis Fungoides & Sézary Syndrome
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that the Committee for Medicinal Products for Human Use (CHMP), the European Medicines Agency’s (EMA) scientific committee, has adopted a Positive Opinion recommending approval of the marketing authorisation of mogamulizumab
Forth Ports wins prestigious award for community work
Forth Ports Limited, one of the UK’s largest port groups, has for the first time won the Corporate Social Responsibility (CSR) award at last night’s Logistics Awards 2018 in London.
Change of Chairs at Abbeyfield Scotland
After a decade of dedicated service on the Board of Abbeyfield Scotland, Chairman James Craigie has retired from the role.
Archangels & Maven back Optoscribe
Co-lead investment in Optoscribe from Archangels and Maven set to facilitate increase in manufacturing capacity and engineering resource, to meet customer demand.
International Track for Loch Duart
Independent salmon farm Loch Duart recognised at Sunday Times HSBC International Track 200 awards ceremony, which featured speakers from boohoo.com and Gymshark
Spreng Thomson team member selected as a top 100 talent under 30
Digital Communication Consultant, Dylan Macdonald, will be taking part in this year’s 100y programme at UPRISE Festival in October.
New funds to fight C. difficile
MGB Biopharma’s anti-bacterial agent for treatment of C. difficile infections, helped by Archangels funding round, to enter Phase II clinical trials
Scotland’s entrepreneurial leaders kick off Fellowship programme
Entrepreneurial Scotland’s Saltire Fellowship Leadership Development programme kicks off with a range of personal development and entrepreneurial challenges.
NICE BACKS Crysvita® (burosumab) for RARE METABOLIC BONE DISORDER, X-LINKED HYPOPHOSPHATAEMIA (XLH)
The positive recommendation marks a step change in the management of XLH for children and young people, and the first significant clinical advancement for the condition in the last 35 years.
